New to Meducation?
Sign up
Already signed up? Log In
view moderators

PercutaneousCoronaryIntervention

Category

Preview
0
1

Ocular Complications After Cardiac Intervention

Retinal artery occlusion is a potential complication of percutaneous coronary intervention. Find out what there is to know.  
medscape.com
over 3 years ago
Preview
0
0

The Year in Cardiology 2015: Coronary Intervention

What new advances and insights did 2015 bring to the field of percutaneous coronary intervention?  
medscape.com
almost 4 years ago
Preview
0
0

Triple Antithrombotic Therapy After Stenting Ups Bleeding CME/CE

: Triple vs dual antithrombotic therapy after percutaneous coronary intervention for myocardial infarction is associated with an increased risk of bleeding complications.  
medscape.org
almost 4 years ago
Www.bmj
0
1

Bivalirudin in the treatment of acute coronary syndrome

Bivalirudin was heralded as the successor to heparin. It is a direct thrombin inhibitor with a more predictable dose response than heparin, a short half life of 22 minutes, and the ability to bind circulating and clot bound thrombin. But does it have genuine advantages over heparin in patients having percutaneous coronary interventions (PCI) for acute coronary syndrome or is it just expensive dilute heparin?  
feeds.bmj.com
almost 4 years ago
Preview
0
3

Bivalirudin in the treatment of acute coronary syndrome

Bivalirudin was heralded as the successor to heparin. It is a direct thrombin inhibitor with a more predictable dose response than heparin, a short half life of 22 minutes, and the ability to bind circulating and clot bound thrombin. But does it have genuine advantages over heparin in patients having percutaneous coronary interventions (PCI) for acute coronary syndrome or is it just expensive dilute heparin?  
feeds.bmj.com
almost 4 years ago
Preview
0
0

Bivalirudin in the treatment of acute coronary syndrome

Bivalirudin was heralded as the successor to heparin. It is a direct thrombin inhibitor with a more predictable dose response than heparin, a short half life of 22 minutes, and the ability to bind circulating and clot bound thrombin. But does it have genuine advantages over heparin in patients having percutaneous coronary interventions (PCI) for acute coronary syndrome or is it just expensive dilute heparin?  
feeds.bmj.com
almost 4 years ago
Preview
0
3

Practical Tools for Sudden Cardiac Arrest Screening: Taking Ownership of Your Patient’s Risk CME

The goal of this activity is to provide clinical guidance on treatment selection strategies for patients at risk of sudden cardiac arrest (SCD) after percutaneous coronary intervention (PCI).  
medscape.org
about 4 years ago
Static.www.bmj
0
11

Delivering thrombectomy for acute stroke using cardiology services

Evidence is mounting for the supplementary benefit over thrombolysis of endovascular therapy in selected patients with acute stroke. Mechanical percutaneous removal of intracerebral clot using an aspiration catheter ensures that the artery is recanalised. Like thrombolysis, the benefits are greater with early treatment, and we need to think about how to achieve this. Evidence on the benefits of rapid primary percutaneous coronary intervention in patients presenting with ST segment elevation myocardial infarction (STEMI) led to a network being set up in the United Kingdom to provide 24 hour care.1 Teams staffing these networks, skilled in opening arteries quickly, could also provide endovascular therapy to selected patients with acute stroke.  
feeds.bmj.com
over 4 years ago
Preview
0
9

Twelve lead electrocardiography after collapse

In the percutaneous coronary intervention unit the patient had a heart rate of 45 beats/min and a blood pressure of 70/40 mm Hg, neither of which responded to atropine and fluid resuscitation. …  
feeds.bmj.com
over 4 years ago
Preview
0
9

Twelve lead electrocardiography after collapse

In the percutaneous coronary intervention unit the patient had a heart rate of 45 beats/min and a blood pressure of 70/40 mm Hg, neither of which responded to atropine and fluid resuscitation. …  
feeds.bmj.com
over 4 years ago
Preview
0
2

Surgery improves survival in diabetic patients with heart disease

Among diabetic patients with severe heart disease, coronary artery bypass grafting (CABG) surgery is better than stenting (percutaneous coronary intervention; PCI) at improving long-term survival and reducing the risk of adverse complications, a study confirms.  
sciencedaily.com
over 4 years ago
Preview
0
2

Surgery improves survival in diabetic patients with heart disease

Among diabetic patients with severe heart disease, coronary artery bypass grafting (CABG) surgery is better than stenting (percutaneous coronary intervention; PCI) at improving long-term...  
medicalnewstoday.com
over 4 years ago
Www.bmj
0
9

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Objective To assess the benefits and risks of short term (<12 months) or extended (>12 months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary intervention with drug eluting stents.  
feeds.bmj.com
over 4 years ago
Www.bmj
0
9

Minimising bleeding during percutaneous coronary intervention

In 2013 more than 92 500 percutaneous coronary intervention (PCI) procedures were performed in the United Kingdom alone.1 Bleeding events are among the most common complications; reported incidences vary between 2.2% and 14%.2 Peri-procedural bleeding has a negative effect on patients’ outcomes—as indicated by higher mortality and morbidity and diminished quality of life—and on metrics of healthcare provision such as length of stay and associated costs.3 Large registries of US patients undergoing PCI have shown that 12.1% of in-hospital mortality is attributable to post-procedural bleeding and suggest a significant association between major bleeding and in-hospital mortality across all strata of bleeding risk.4 The 2011 American Heart Association guidelines state that all patients should be evaluated for risk of bleeding before PCI (class of recommendation 1, level of evidence C).5  
feeds.bmj.com
over 4 years ago
Www.bmj
0
14

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Objective To assess the benefits and risks of short term (<12 months) or extended (>12 months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary intervention with drug eluting stents.  
feeds.bmj.com
over 4 years ago
Www.bmj
0
10

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Objective To assess the benefits and risks of short term (<12 months) or extended (>12 months) dual antiplatelet therapy (DAPT) versus standard 12 month therapy, following percutaneous coronary intervention with drug eluting stents.  
feeds.bmj.com
over 4 years ago
Www.bmj
1
14

Optimism and consent to treatment

We know that patients and doctors tend to overestimate the benefits of treatment and underestimate the harms. We also know that people’s natural optimism is often boosted by the systematic optimism bias of the medical literature (Br J Psych 2010;197:441-7, doi:10.1192/bjp.bp.110.078006; PLoS One 2014;9(5):e98246, doi:10.1371/journal.pone.0098246). But in the case of percutaneous coronary intervention there is no such excuse. Experts and guidelines are clear: it improves symptoms but not survival. Nor does it reduce the risk of myocardial infarction. It should be offered to patients with stable coronary artery disease only if medical treatment is failing to manage their angina.  
bmj.com
about 5 years ago
Preview
1
34

Angioplasty (PCI)

Angioplasty (percutaneous coronary intervention - PCI) This is also sometimes called PTCA - Percutaneous Transluminal Coronary Angioplasty  
almostadoctor.com - free medical student revision notes
over 5 years ago